Evidence map›Paper›PMID 39097609›Full record

Trial reportTranslational psychiatry2024

Nicotine reduces discrimination between threat and safety in the hippocampus, nucleus accumbens and amygdala.

Madeleine Mueller, Tahmine Fadai, Jonas Rauh, Jan Haaker

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Madeleine MuellerUniversity Medical Center Hamburg-Eppendorf (Germany), Department of Systems Neuroscience, Hamburg, Germany. dr.madmueller@gmail.com.ORCID 0000-0002-0009-3636
Tahmine FadaiUniversity Medical Center Hamburg-Eppendorf (Germany), Department of Systems Neuroscience, Hamburg, Germany.
Jonas RauhUniversity Medical Center Hamburg-Eppendorf (Germany), Department of Systems Neuroscience, Hamburg, Germany.ORCID 0000-0003-0538-7593
Jan HaakerUniversity Medical Center Hamburg-Eppendorf (Germany), Department of Systems Neuroscience, Hamburg, Germany. j.haaker@uke.de.ORCID 0000-0001-8366-9559

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 7470/3-1Deutsche Forschungsgemeinschaft (German Research Foundation) SFB 936 (178316478 - C06)Deutsche Forschungsgemeinschaft (German Research Foundation) TRR 289 (422744262 - A06)
6 · The paper itself

Abstract

Nicotine intake is linked to the maintenance and development of anxiety disorders and impairs adaptive discrimination of threat and safety in rodents and humans. Yet, it is unclear if nicotine exerts a causal pharmacological effect on the affective and neural mechanisms that underlie aversive learning. We conducted a pre-registered, pseudo-randomly and double-blinded pharmacological fMRI study to investigate the effect of acute nicotine on Fear Acquisition and Extinction in non-smokers (n = 88). Our results show that nicotine administration led to decreased discrimination between threat and safety in subjective fear. Nicotine furthermore decreased differential (threat vs. safety) activation in the hippocampus, which was functionally coupled with Nucleus Accumbens and amygdala, compared to placebo controls. Additionally, nicotine led to enhanced physiological arousal to learned threats and overactivation of the ventral tegmental area. This study provides mechanistic evidence that single doses of nicotine impair neural substrates of adaptive aversive learning in line with the risk for the development of pathological anxiety.

Indexed as

AmygdalaFearHippocampusNicotineNucleus AccumbensAdultDiscrimination, PsychologicalDouble-Blind MethodExtinction, PsychologicalFemaleHumansMagnetic Resonance ImagingMaleNicotinic AgonistsYoung AdultNicotineNicotinic Agonists

Identifiers

PMID39097609
PMCPMC11297927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.